section name header

Pronunciation

trye-FAR-oh-teen

Classifications

Therapeutic Classification: antiacne agents

Pharmacologic Classification: retinoids

Indications

REMS


Action

  • Stimulates retinoic acid receptors, resulting in anti-inflammatory effects.
Therapeutic effects:
  • Decreased severity of acne vulgaris.

Pharmacokinetics

Absorption: Minimal systemic absorption.

Distribution: Unknown.

Protein Binding: >99%.

Metabolism/Excretion: Primarily metabolized by CYP2C8, CYP2C9, and CYP3A4. Primarily excreted in feces.

Half-Life: 2–9 hr.

Time/Action Profile

(improvement in lesions)

ROUTEONSETPEAKDURATION
Topicalwithin 12 wksUnknownUnknown

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Local: burning/stinging, erythema, itching, photosensitivity, scaling

Interactions

Drug-drug:

Route/Dosage

Availability

Assessment

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Aklief

Code

NDC Code